Extracorporeal shock wave therapy for treating dyspareunia: A prospective, randomized, double-blind, placebo-controlled study
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11510%2F21%3A10438123" target="_blank" >RIV/00216208:11510/21:10438123 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/21:10438123
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=V4lEptO.TO" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=V4lEptO.TO</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.rehab.2021.101545" target="_blank" >10.1016/j.rehab.2021.101545</a>
Alternative languages
Result language
angličtina
Original language name
Extracorporeal shock wave therapy for treating dyspareunia: A prospective, randomized, double-blind, placebo-controlled study
Original language description
Background: Dyspareunia is a genital pain during or after penile-vaginal sexual intercourse. It is a painful spasm of the pelvic muscles that partly or entirely disables vaginal penetration. Objectives: We examined the effect of extracorporeal shock wave therapy (ESWT) on idiopathic non organic dyspareunia in women. A prospective, randomized, double-blind, placebo-controlled study was conducted. Methods: The study included 62 women who reported dyspareunia. Patients in the treatment and placebo groups received ESWT perineally weekly for 4 consecutive weeks; placebo patients received placebo stand-off treatment. The grade of dyspareunia was estimated by using the Marinoff Dyspareunia Scale and subjective pain intensity on a visual analog scale (VAS) before and after treatment. Follow-ups were conducted 1, 4 and 12 weeks after the final ESWT session. Results: The study included 61 women. The treatment but not placebo group differed by the Marinoff Dyspareunia Scale and VAS. Differences before and after treatment within groups were all P < 0.001 and between groups, P < 0.001. Pain reduction was always > 30%. The effect sizes were both large: Marinoff 0.825 and VAS 0.883. Conclusions: ESWT significantly reduced subjective pain in our women treated for dyspareunia.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30214 - Obstetrics and gynaecology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Annals of Physical and Rehabilitation Medicine
ISSN
1877-0657
e-ISSN
—
Volume of the periodical
64
Issue of the periodical within the volume
6
Country of publishing house
FR - FRANCE
Number of pages
5
Pages from-to
101545
UT code for WoS article
000741054400005
EID of the result in the Scopus database
2-s2.0-85111231470